Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.71B |
| 2 |
Microsoft
MSFT
|
+$3.52B |
| 3 |
Amazon
AMZN
|
+$2.04B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.87B |
| 5 |
Eli Lilly
LLY
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.8B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.78B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$703M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$611M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.3% |
| 2 | Healthcare | 12.11% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBIO
6076
Crescent Biopharma
CBIO
$644M
| $49.5K | ﹤0.01% |
163
-273
| -63% | -$40.2K |
|
6077
Transcontinental Realty Investors
TCI
$315M
| $49.3K | ﹤0.01% |
1,117
+202
| +22% | +$8.44K |
|
|
PTNR
6078
DELISTED
Partner Communications
PTNR
| $49.2K | ﹤0.01% |
6,900
-1,091
| -14% | -$7.9K |
|
6079
Valaris Ltd Warrants
VAL.WS
$813M
| $48.9K | ﹤0.01% |
4,107
+30
| +0.7% | +$322 |
|
|
DRRX
6080
DELISTED
DURECT Corp
DRRX
| $48.8K | ﹤0.01% |
14,103
-1,858
| -12% | -$8.84K |
|
6081
Global X Genomics & Biotechnology ETF
GNOM
$87.5M
| $48.6K | ﹤0.01% |
960
-1,947
| -67% | -$100K |
|
6082
Franklin Wireless
FKWL
$27.9M
| $48.5K | ﹤0.01% |
10,883
-4,018
| -27% | -$14K |
|
6083
Innovator US Equity Power Buffer ETF July
PJUL
$1.29B
| $48.2K | ﹤0.01% |
1,598
+799
| +100% | +$23.9K |
|
6084
Zevra Therapeutics
ZVRA
$682M
| $48.1K | ﹤0.01% |
10,470
-7,140
| -41% | -$36.3K |
|
6085
Grove Collaborative
GROV
$45.3M
| $48K | ﹤0.01% |
24,075
+24,073
| +1,203,650% | +$123K |
|
6086
BGSF Inc
BGSF
$59.3M
| $48K | ﹤0.01% |
3,134
+552
| +21% | +$7.05K |
|
|
MEKA
6087
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
| $47.9K | ﹤0.01% |
4,800
-1,670,653
| -100% | -$16.6M |
|
|
CLSD
6088
DELISTED
Clearside Biomedical
CLSD
| $47.8K | ﹤0.01% |
2,843
-5,002
| -64% | -$90.1K |
|
6089
-1x Short VIX Futures ETF
SVIX
$165M
| $47.5K | ﹤0.01% |
3,241
-10,179
| -76% | -$129K |
|
|
VIVS
6090
VivoSim Labs
VIVS
$1.27M
| $47.5K | ﹤0.01% |
2,806
-14
| -0.5% | -$280 |
|
6091
MediWound
MDWD
$178M
| $47.5K | ﹤0.01% |
3,519
-399
| -10% | -$4.04K |
|
|
NEWP
6092
New Pacific Metals
NEWP
$1.16B
| $47.5K | ﹤0.01% |
21,092
+9,035
| +75% | +$20.4K |
|
6093
Catheter Precision
VTAK
$1.11M
| $47.5K | ﹤0.01% |
+42
| New | +$34.8K |
|
6094
RPAR Risk Parity ETF
RPAR
$582M
| $47.4K | ﹤0.01% |
2,545
+1,145
| +82% | +$21K |
|
|
RKLY
6095
DELISTED
Rockley Photonics Holdings Limited
RKLY
| $47.2K | ﹤0.01% |
336,929
+155,030
| +85% | +$59.1K |
|
6096
Westwood Holdings Group
WHG
$183M
| $47K | ﹤0.01% |
4,223
-6,210
| -60% | -$65.4K |
|
6097
Katapult Holdings
KPLT
$31.6M
| $46.9K | ﹤0.01% |
1,962
+28
| +1% | +$669 |
|
6098
UVA Unconstrained Medium-Term Fixed Income ETF
FFIU
$52.4M
| $46.8K | ﹤0.01% |
2,189
| – | – |
|
6099
ProShares UltraPro Dow 30
UDOW
$937M
| $46.8K | ﹤0.01% |
1,652
-2,238
| -58% | -$61.4K |
|
|
GENE
6100
DELISTED
Genetic Technologies Ltd.
GENE
| $46.7K | ﹤0.01% |
10,036
-430
| -4% | -$2.44K |
|
Similar funds
Morgan Stanley's Q4 2022 Portfolio in Review
As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 199 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.
- Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
- Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
- Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
- Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
- Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
- Morgan Stanley opened 199 new positions and closed 311 in Q4 2022.
- Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.
Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.